Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
02/08/2007 | US20070032434 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
02/08/2007 | US20070031973 Triazine derivatives as universal peptide isotope tag reagents (U-PIT) |
02/08/2007 | US20070028961 Organic dye compositions and use thereof in photovoltaic cells |
02/08/2007 | DE102005035575A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease |
02/08/2007 | CA2617679A1 Inhibitors of serine proteases |
02/08/2007 | CA2617170A1 Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders |
02/08/2007 | CA2617099A1 Macrocyclic inhibitors of hepatitis c virus |
02/08/2007 | CA2617096A1 Macrocyclic inhibitors of hepatitis c virus |
02/08/2007 | CA2616937A1 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
02/08/2007 | CA2616159A1 Benzimidazoles useful as inhibitors of protein kinases |
02/08/2007 | CA2606004A1 Dipiperazinyl ketones and related analogues |
02/07/2007 | EP1749828A1 Process for preparing an angiotensin II receptor antagonist |
02/07/2007 | EP1749817A1 Neurogenic pain control agent composition |
02/07/2007 | EP1749000A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
02/07/2007 | EP1748999A1 Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation |
02/07/2007 | EP1748991A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents |
02/07/2007 | EP1748987A2 2-propene-1-ones as hsp 70 inducers |
02/07/2007 | EP1748985A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
02/07/2007 | EP1748983A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease |
02/07/2007 | EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists |
02/07/2007 | EP1651622B1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
02/07/2007 | EP1401813B1 New indole derivatives with 5-ht6 receptor affinity |
02/07/2007 | CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
02/07/2007 | CN1910174A Indolylmaleimide derivatives |
02/07/2007 | CN1910173A Indolylmaleimide derivatives as PKC inhibitors |
02/07/2007 | CN1910159A 2,4-diaminopyrimidines and their use for inducing cardiomyogenesis |
02/07/2007 | CN1910156A Malononitrile compound as pesticide |
02/07/2007 | CN1909901A A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride |
02/07/2007 | CN1907983A Preparation of similar cyclic dipeptide compound 1,4-(benzimidazolemethyl)-2,5-piperazinedione and application thereof |
02/07/2007 | CN1298716C 1-[(indol-3-yl)carbonyl] piperazine derivatives and their medical compositions |
02/07/2007 | CN1298704C Isatine derivatives with neurotrophic activity |
02/06/2007 | US7173131 Anthryl derivative group substituted compound, and organic luminescent device making use of same |
02/06/2007 | US7173130 Detection of transmembrane potentials by optical methods |
02/06/2007 | US7173129 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
02/06/2007 | US7173054 Respiratory syncytial virus replication inhibitors |
02/06/2007 | US7173051 Inhibitors of cathepsin S |
02/06/2007 | US7173048 Indolyl derivatives as liver-X-receptor (LXR) modulators |
02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
02/06/2007 | US7173039 Compounds that modulate or inhibit enzymes for occular diseases |
02/06/2007 | US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
02/06/2007 | US7173028 Pyrimidine derivatives |
02/06/2007 | US7173027 Provide a physiological effect to a subject |
02/06/2007 | US7173024 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use |
02/06/2007 | US7172907 2-{5-[1-(5-carboxypentyl)-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene]-3-cyano-1,3-pentadienyl}-1,3,3-trimethyl-3H-indolinium (mesocyano Cy5); for sequencing, microarrays, flow cytometry and proteomics |
02/01/2007 | WO2007014198A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders |
02/01/2007 | WO2007013323A1 4,5-di(5-tetrazolyl)-[1,2,3]triazole compound and process for producing the same |
02/01/2007 | WO2007013101A1 PROCESS FOR PRODUCING 2-(N-BUTYL)-3-[[2'-(TETRAZOL-5-YL)BIPHENYL- 4-YL]METHYL]-l,3-DIAZASPIRO[4.4] NON-1-EN-4-ONE |
02/01/2007 | WO2007013096A1 Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole) |
02/01/2007 | WO2007012849A2 MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP |
02/01/2007 | WO2007012670A2 Compounds derived from 5-benzylidene imidazolidine 2,4-dione and their use as mchr-1 antagonists |
02/01/2007 | WO2007012579A1 Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
02/01/2007 | WO2006129120A3 Benzotriazepinone derivatives |
02/01/2007 | WO2006031806A3 2-thiopyrimidinones as therapeutic agents |
02/01/2007 | WO2005112919A3 Self-immolative linkers and drug conjugates |
02/01/2007 | US20070027327 combining an isatin and ethylene glycol, reacting the solution with aqueous hydrazine and isolating the 2-oxindole; efficient route to preparing 2-oxindoles using inexpensive reagents, and simple purifications |
02/01/2007 | US20070027322 N-substituted carbamoyloxyalkyl-azolium derivatives |
02/01/2007 | US20070027318 Quinoline derivatives and quinazoline derivatives |
02/01/2007 | US20070027312 Methods and intermediates for the synthesis of porphyrins |
02/01/2007 | US20070027311 Methods and intermediates for the synthesis of porphyrins |
02/01/2007 | US20070027310 Novel ligands and methods for preparing same |
02/01/2007 | US20070027278 monomers of acetylenic homo- or copolymers; cured polymers has low dielectric constant as insulating layers in microelectronic devices |
02/01/2007 | US20070027201 Use of progesterone receptor modulators |
02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
02/01/2007 | US20070027199 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation |
02/01/2007 | US20070027196 Activator of peroxisome proliferator-activated receptor delta |
02/01/2007 | US20070027188 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye |
02/01/2007 | US20070027186 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
02/01/2007 | US20070027173 Indol-3-yl-carbonyl-spiro-piperidine derivatives as Vla receptor antagonists |
02/01/2007 | US20070027163 Indol-3-y-carbonyl-piperidin and piperazin-derivatives |
02/01/2007 | US20070027161 Central nervous system disorders, Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease (enhancement of cognitive memory), sleep disorders, feeding disorders such as anorexia |
02/01/2007 | US20070027160 Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor |
02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
02/01/2007 | US20070027157 Quinoxalinone-3-one derivatives as orexin receptor antagonists |
02/01/2007 | US20070027155 Biaryl piperazinyl-pyridine analogues |
02/01/2007 | US20070027154 Insecticide for agricultural or horticultural use and method of use thereof |
02/01/2007 | US20070027150 2-Amino-quinazolin-5-ones |
02/01/2007 | US20070027149 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors |
02/01/2007 | US20070027147 Biarylurea derivatives |
02/01/2007 | US20070027145 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
02/01/2007 | US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
02/01/2007 | US20070027140 {2-[(1-cyclopropylmethyl-6-fluoro-1H-indole-3-carbonyl)-amino]-thiazol-5-ylsulfanyl}-acetic acid, used for treating non-insulin dependent diabetes, dyslipidemia, hyperlipidemia, hypertension, obesity and as dietetics |
02/01/2007 | US20070027139 Piperazinyl-quinoline derivatives useful for the treatment of cns disorders |
02/01/2007 | US20070027135 Apoptosis promoters |
02/01/2007 | US20070027131 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents |
02/01/2007 | US20070027115 Triazole derivatives useful in therapy |
02/01/2007 | US20070026384 Detection of transmembrane potentials by optical methods |
02/01/2007 | CA2616985A1 Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-i-yl methylene or a pyrimidin-2yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group |
02/01/2007 | CA2616576A1 Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
02/01/2007 | CA2614919A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders |
02/01/2007 | CA2614288A1 Fungicidal carboxamides |
01/31/2007 | EP1747216A1 Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
01/31/2007 | EP1747206A1 Amino-tetrazoles analogues and methods of use |
01/31/2007 | EP1747204A1 Tri-substituted ureas as cytokine inhibitors |
01/31/2007 | EP1747203A1 Scalable synthesis of imidazole derivatives |
01/31/2007 | EP1747021A2 Self-immolative linkers and drug conjugates |
01/31/2007 | EP1746997A2 3-(4-heteroarylcyclohexylamino) czclopentanecarboxamides as modulators of chemokine receptors |
01/31/2007 | EP1746880A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof |
01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
01/31/2007 | CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor |